Fact CheckerSign in

NCT07833748Recruiting

Integrated Motor-Cognitive Training in Parkinson's Disease: A Feasibility Study

Source: ClinicalTrials.gov · Last updated 22 Sept 2026

Brief summary (registry, in English)

Parkinson's disease is a progressive neurodegenerative condition characterized by both motor symptoms (such as bradykinesia, rigidity, tremor, and postural instability) and non-motor symptoms, including cognitive impairments (affecting working memory, executive functions, and attention). Combined interventions that target both domains simultaneously or consecutively have shown potential to produce superior benefits compared to isolated motor or cognitive training. The purpose of this study is to evaluate the feasibility, adherence, and preliminary clinical results of efficacy of an integrated and combined motor-cognitive rehabilitation training in patients diagnosed with Parkinson's disease. This feasibility study will enroll 12 participants with Parkinson's disease. All participants will undergo a comprehensive 10-session integrated rehabilitation program combining digital cognitive individual stimulation and group functional motor training. The primary focus is to assess acceptability, safety, and adherence to this combined approach, while secondary outcomes will observe changes in relevant cognitive and motor clinical variables.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
12 (estimated)
First submitted
10 Sept 2026
Start date
1 Jun 2026
Primary completion date
31 Aug 2026
Lead sponsor
University Hospital of Ferrara
NCT number
NCT07833748

What you commit to

  • Study type: Interventional
  • Planned participants: 12
  • From 1 Jun 2026 to the primary completion date, 31 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concomitant major neurological or psychiatric disorders
  • Changes in baseline pharmacological therapy within 3 months prior to enrollment

Other illness

  • Severe cardio-pulmonary, renal, or hepatic diseases

Who the study is looking for

  • Diagnosis of Parkinson's disease
  • Presence of motor symptoms attributable to Parkinson's disease
  • Availability to participate in both treatments (cognitive and motor)
  • Severity of symptoms compatible with participation in group physical therapy
  • Absence of other medical conditions that could interfere with treatment delivery
  • Montreal Cognitive Assessment (MoCA) score \>= 18
  • Consent to participate in group-based motor training
  • Absence of falls in the 3 months prior to baseline evaluation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ferrara University Hospital
Coordinator of this site? Confirm its status
FerraraItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.